Patents by Inventor Jaswant S. Gidda

Jaswant S. Gidda has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Naphthylpiperazinyl compounds useful for treating 5HT.sub.2B receptor mediated conditions
    Patent number: 5736544
    Abstract: The present invention provides methods for binding a 5-HT.sub.2B receptor in mammals using both known and novel compounds. Further, the invention provides a method for treating or preventing 5-HT.sub.2B related conditions. Finally, the invention provides an article of manufacture.
    Type: Grant
    Filed: March 25, 1996
    Date of Patent: April 7, 1998
    Assignee: Eli Lilly and Company
    Inventors: James E. Audia, Marlene L. Cohen, Jaswant S. Gidda, David L. G. Nelson
  • Method for treating 5-HT.sub.2B receptor related conditions
    Patent number: 5705519
    Abstract: The present invention provides methods for binding a 5-HT.sub.2B receptor in mammals using a both known and novel compounds. Further, the invention provides a method for treating or preventing 5-HT.sub.2B related conditions. Finally, the invention provides an article of manufacture.
    Type: Grant
    Filed: May 12, 1995
    Date of Patent: January 6, 1998
    Assignee: Eli Lilly and Company
    Inventors: James E. Audia, Marlene Cohen, Jaswant S. Gidda, David L. Nelson
  • Method for treating 5HT.sub.2B receptor related conditions
    Patent number: 5688807
    Abstract: The present invention provides methods for binding a 5-HT.sub.2B receptor in mammals using a both known and novel compounds. Further, the invention provides a method for treating or preventing 5-HT.sub.2B related conditions. Finally, the invention provides an article of manufacture.
    Type: Grant
    Filed: February 6, 1995
    Date of Patent: November 18, 1997
    Assignee: Eli Lilly and Company
    Inventors: James E. Audia, Marlene L. Cohen, Jaswant S. Gidda, David L. G. Nelson
  • Method of inhibiting gastric acid secretion with 8-substituted-2-amino-1,2,3,4-tetrahydronapthalene
    Patent number: 5594034
    Abstract: The present invention provides a method of inhibiting gastric acid secretion in mammals by administering a 5-HT1A agonist compound or a pharmaceutically acceptable salt thereof.
    Type: Grant
    Filed: April 7, 1995
    Date of Patent: January 14, 1997
    Assignee: Eli Lilly and Company
    Inventors: Jaswant S. Gidda, John M. Schaus
  • Method of inhibiting gastric acid secretion with 5-substituted-3-aminochromane
    Patent number: 5594025
    Abstract: The present invention provides a method of inhibiting gastric acid secretion in mammals by administering a 5-HT1A agonist compound or a pharmaceutically acceptable salt thereof.
    Type: Grant
    Filed: April 7, 1995
    Date of Patent: January 14, 1997
    Assignee: Eli Lilly and Company
    Inventors: Jaswant S. Gidda, John M. Schaus
  • Method of inhibiting gastric acid secretion with aryloxypropanolamines
    Patent number: 5576352
    Abstract: The present invention provides a method of inhibiting gastric acid secretion in mammals by administering a 5-HT1A agonist compound or a pharmaceutically acceptable salt thereof.
    Type: Grant
    Filed: February 13, 1995
    Date of Patent: November 19, 1996
    Assignee: Eli Lilly and Company
    Inventors: Jaswant S. Gidda, John M. Schaus
  • Method of inhibiting gastric acid secretion with 4- amino-1, 3, 4, 5 tetrahydrobenzo [c,d]indoles
    Patent number: 5457120
    Abstract: The present invention provides a method of inhibiting gastric acid secretion in mammals by administering a 5-HT1A agonist compound or a pharmaceutically acceptable salt thereof.
    Type: Grant
    Filed: March 29, 1994
    Date of Patent: October 10, 1995
    Assignee: Eli Lilly and Company
    Inventors: Jaswant S. Gidda, John M. Schaus
  • Isoxazole derivatives for the treatment of irritable bowel syndrome
    Patent number: 5434174
    Abstract: Methods of treating Irritable Bowel Syndrome (IBS) using a series of isoxazole derivatives that have both 5-HT1A agonist and M1 muscarinic activities, and formulations adapted for the treatment of IBS comprising those derivatives.
    Type: Grant
    Filed: April 20, 1993
    Date of Patent: July 18, 1995
    Assignee: Eli Lilly and Company
    Inventors: Jaswant S. Gidda, John M. Schaus
  • Method of treating inflammatory bowel disease
    Patent number: 5387690
    Abstract: Provided is a method of treating inflammatory bowel disease in mammals utilizing certain benzyl-substituted rhodanine derivatives. Also provided are novel benzyl-substituted rhodanine derivatives and pharmaceutical compositions thereof, as well as a novel process for selectively isolating in substantially pure enantiomeric form the enantiomers of certain racemic benzyl-substituted rhodanine derivatives.
    Type: Grant
    Filed: May 28, 1993
    Date of Patent: February 7, 1995
    Assignee: Eli Lilly and Company
    Inventors: Jaswant S. Gidda, Jill A. Panetta, Michael L. Phillips
  • Method of inhibiting gastric acid secretion with 2-phenylcyclopropylamines
    Patent number: 5340838
    Abstract: The present invention provides a method of inhibiting gastric acid secretion in mammals by administering a 5-HT1A agonist compound or a pharmaceutically acceptable salt thereof.
    Type: Grant
    Filed: May 26, 1993
    Date of Patent: August 23, 1994
    Assignee: Eli Lilly and Company
    Inventors: Jaswant S. Gidda, John M. Schaus
  • Method of inhibiting gastric acid secretion with n-arylpiperazines
    Patent number: 5258379
    Abstract: The present invention provides a method of inhibiting gastric acid secretion in mammals by administering a 5-HT1A agonist compound or a pharmaceutically acceptable salt thereof.
    Type: Grant
    Filed: June 15, 1992
    Date of Patent: November 2, 1993
    Assignee: Eli Lilly and Company
    Inventors: Jaswant S. Gidda, John M. Schaus
  • Method of treating inflammatory bowel disease
    Patent number: 5216002
    Abstract: Provided is a method of treating inflammatory bowel disease in mammals utilizing certain benzyl-substituted rhodanine derivatives. Also provided are novel benzyl-substituted rhodanine derivatives and pharmaceutical compositions thereof, as well as a novel process for selectively isolating in substantially pure enantiomeric form the enantiomers of certain racemic benzyl-substituted rhodanine derivatives.
    Type: Grant
    Filed: December 7, 1990
    Date of Patent: June 1, 1993
    Assignee: Eli Lilly and Company
    Inventors: Jaswant S. Gidda, Jill A. Panetta, Michael L. Phillips
  • Method of inhibiting gastric acid secretion with benzodioxanes
    Patent number: 5158956
    Abstract: The present invention provides a method of inhibiting gastric acid secretion in mammals by administering a 5-HT1A agonist compound or a pharmaceutically acceptable salt thereof.
    Type: Grant
    Filed: May 29, 1991
    Date of Patent: October 27, 1992
    Assignee: Eli Lilly and Company
    Inventors: Jaswant S. Gidda, John M. Schaus
  • Method of inhibiting gastric acid secretion
    Patent number: 5096908
    Abstract: The present invention provides a method of inhibiting gastric acid secretion in mammals by administering a 5-HT1A agonist compound or a pharmaceutically acceptable salt thereof.
    Type: Grant
    Filed: May 4, 1990
    Date of Patent: March 17, 1992
    Assignee: Eli Lilly and Company
    Inventors: Jaswant S. Gidda, John M. Schaus
  • Method for treating gastrointestinal disorders
    Patent number: 4920102
    Abstract: Novel ring-contracted macrolides which enhance gastrointestinal motility and novel methods and compositions for treating gtastrointestinal disorders in animals with these macrolides and with certain other previously known ring-contracted macrolides are provided.
    Type: Grant
    Filed: April 18, 1988
    Date of Patent: April 24, 1990
    Assignee: Eli Lilly and Company
    Inventors: Jaswant S. Gidda, Herbert A. Kirst, David W. Robertson
  • Thiadiazole oxides for treating gastrointestinal motility disorders
    Patent number: 4829073
    Abstract: The present invention provides a method for treating gastrointestinal motility disorders and thiadiazole oxide compounds for use in the method.
    Type: Grant
    Filed: May 12, 1988
    Date of Patent: May 9, 1989
    Assignee: Bristol-Myers Company
    Inventors: Jaswant S. Gidda, Ivo Monkovic